全球BETA地中海貧血檢測市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

預計全球BETA地中海貧血檢測市場需求將從2022年的5018.3億美元增至2030年的近12146.3億美元，2023-2030年研究期間年複合成長率為9.2%。

BETA地中海貧血是一种血液疾病。這是一種遺傳性疾病，身體產生的血紅蛋白比平常少。血紅蛋白是一種含有鐵的蛋白質，存在於紅細胞中；血紅蛋白的主要功能是將氧氣輸送到全身的細胞。 BETA地中海貧血會導致大量血細胞被破壞。該病的特點是貧血、呼吸短促、疲勞、心跳加快、煩躁、黃疸和生長緩慢。 BETA地中海貧血檢測包括輸血和鐵螯合療法。

市場動態：

地中海貧血患病率的增加可能是市場成長的主要貢獻者。影響BETA地中海貧血市場成長率的另一個重要因素是醫療保健支出的增加。此外，早期基因檢測和諮詢採用率的上升將促進市場成長。此外，政府提高地中海貧血意識的措施可能會推動市場成長。此外，研發活動的增加和有效治療方法的推出提供了利潤豐厚的市場機會。然而，與治療相關的高成本可能會限制市場成長。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球BETA地中海貧血檢測市場的各個細分市場進行了包容性評估。 BETA地中海貧血檢測行業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的BETA地中海貧血測試市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。 BETA地中海貧血檢測市場的主要參與者包括 MedGenome、3B BlackBio Biotech India Limited、Bio-Rad Laboratories Inc.、ViennaLab Diagnostics、Thermo Fisher Scientific Inc.、PerkinElmer Inc.、BioMedomics Inc.、Asper Biogene、Tosoh Bioscience Inc.。該部分包含競爭格局的整體視圖，其中包括各種戰略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：BETA 地中海貧血測試 - 行業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 行業動態
• 波特五力分析
• 市場吸引力分析
  • 按產品分類的市場吸引力分析
  • 按技術分類的市場吸引力分析
  • 按類型分類的市場吸引力分析
  • 最終用戶的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷管道發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球 BETA 地中海貧血測試市場分析：按產品分類

• 按產品概述
• 歷史和預測數據
• 按產品分析
• 套件
• 耗材

第 7 章：全球 BETA 地中海貧血測試市場分析：按技術分類

• 按技術概述
• 歷史和預測數據
• 按技術分析
• 產前診斷
• 全血細胞計數
• DNA檢測
• 其他

第 8 章：全球 BETA 地中海貧血測試市場分析：按類型

• 按類型概述
• 歷史和預測數據
• 按類型分析
• 重型地中海貧血
• 中間型地中海貧血

第 9 章：全球 BETA 地中海貧血測試市場分析：按最終用戶分類

• 最終用戶概述
• 歷史和預測數據
• 最終用戶分析
• 醫院和專科診所
• 診斷中心
• 其他

第 10 章：全球 BETA 地中海貧血測試市場分析：按地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概述、歷史和預測銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家/地區銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、歷史和預測銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家/地區銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概述、歷史和預測銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳大利亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概述、歷史和預測銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家/地區銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概述、歷史和預測銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 11 章：BETA 地中海貧血測試公司的競爭格局

• BETA地中海貧血檢測市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 12 章：公司簡介

• 頂級公司股票分析
• 市場集中度
• MedGenome
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• 3B BlackBio Biotech India Limited
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Bio-Rad Laboratories Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• ViennaLab Diagnostics
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Thermo Fisher Scientific Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• PerkinElmer Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• BioMedomics Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Asper Biogene
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Tosoh Bioscience Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

The global demand for Beta Thalassemia Testing Market is presumed to reach the market size of nearly USD 1214.63 BN by 2030 from USD 501.83 BN in 2022 with a CAGR of 9.2% under the study period 2023 - 2030.

Beta thalassemia is a type of blood disorder. This is a genetic disease in which the body produces less haemoglobin than usual. Haemoglobin is a protein containing iron and is present in red blood cells; the major function of haemoglobin is to carry oxygen to the body cells throughout the body. Beta thalassemia causes a huge number of blood cells to be destroyed. The condition is characterized by anemia, shortness of breath, fatigue, fast heartbeat, irritability, jaundice, and slow growth. Beta thalassemia testing consists of blood transfusions and iron chelation therapy.

MARKET DYNAMICS:

The increase in the prevalence of thalassemia may be a major contributor to market growth. Another significant factor influencing the beta thalassemia market growth rate is the rising healthcare expenditure. Also, the rise in the adoption rate of early genetic testing and counselling will boost market growth. Moreover, government measures to raise awareness of thalassemia may propel market growth. Furthermore, increased R&D activities and the launch of effective treatments offer lucrative market opportunities. However, the high cost associated with the treatment may limit the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of beta thalassemia testing. The growth and trends of beta thalassemia testing industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the beta thalassemia testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Kits
• Consumables

By Technology

• Prenatal Diagnosis
• Complete Blood Count
• Dna Testing
• Others

By Type

• Thalassemia Major
• Thalassemia Intermedia

By End-User

• Hospitals & Specialty Clinics
• Diagnostics Centers
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Beta Thalassemia Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the beta thalassemia testing market include MedGenome, 3B BlackBio Biotech India Limited, Bio-Rad Laboratories Inc., ViennaLab Diagnostics, Thermo Fisher Scientific Inc., PerkinElmer Inc., BioMedomics Inc., Asper Biogene, Tosoh Bioscience Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . BETA THALASSEMIA TESTING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Technology
  • 3.7.3 Market Attractiveness Analysis By Type
  • 3.7.4 Market Attractiveness Analysis By End-user
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Kits Historic and Forecast Sales by Regions
• 6.5 Consumables Historic and Forecast Sales by Regions

7 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY TECHNOLOGY

• 7.1 Overview by Technology
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Technology
• 7.4 Prenatal Diagnosis Historic and Forecast Sales by Regions
• 7.5 Complete Blood Count Historic and Forecast Sales by Regions
• 7.6 DNA Testing Historic and Forecast Sales by Regions
• 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY TYPE

• 8.1 Overview by Type
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Type
• 8.4 Thalassemia Major Historic and Forecast Sales by Regions
• 8.5 Thalassemia Intermedia Historic and Forecast Sales by Regions

9 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY END-USER

• 9.1 Overview by End-user
• 9.2 Historical and Forecast Data
• 9.3 Analysis by End-user
• 9.4 Hospitals & Specialty Clinics Historic and Forecast Sales by Regions
• 9.5 Diagnostics Centers Historic and Forecast Sales by Regions
• 9.6 Others Historic and Forecast Sales by Regions

10 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1. Overview, Historic and Forecast Sales Analysis
  • 10.3.2. North America By Segment Sales Analysis
  • 10.3.3. North America By Country Sales Analysis
  • 10.3.4. United State Sales Analysis
  • 10.3.5. Canada Sales Analysis
  • 10.3.6. Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1. Overview, Historic and Forecast Sales Analysis
  • 10.4.2. Europe by Segment Sales Analysis
  • 10.4.3. Europe by Country Sales Analysis
  • 10.4.4. United Kingdom Sales Analysis
  • 10.4.5. France Sales Analysis
  • 10.4.6. Germany Sales Analysis
  • 10.4.7. Italy Sales Analysis
  • 10.4.8. Russia Sales Analysis
  • 10.4.9. Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1. Overview, Historic and Forecast Sales Analysis
  • 10.5.2. Asia Pacific by Segment Sales Analysis
  • 10.5.3. Asia Pacific by Country Sales Analysis
  • 10.5.4. China Sales Analysis
  • 10.5.5. India Sales Analysis
  • 10.5.6. Japan Sales Analysis
  • 10.5.7. South Korea Sales Analysis
  • 10.5.8. Australia Sales Analysis
  • 10.5.9. Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1. Overview, Historic and Forecast Sales Analysis
  • 10.6.2. Latin America by Segment Sales Analysis
  • 10.6.3. Latin America by Country Sales Analysis
  • 10.6.4. Brazil Sales Analysis
  • 10.6.5. Argentina Sales Analysis
  • 10.6.6. Peru Sales Analysis
  • 10.6.7. Chile Sales Analysis
  • 10.6.8. Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1. Overview, Historic and Forecast Sales Analysis
  • 10.7.2. Middle East & Africa by Segment Sales Analysis
  • 10.7.3. Middle East & Africa by Country Sales Analysis
  • 10.7.4. Saudi Arabia Sales Analysis
  • 10.7.5. UAE Sales Analysis
  • 10.7.6. Israel Sales Analysis
  • 10.7.7. South Africa Sales Analysis
  • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE BETA THALASSEMIA TESTING COMPANIES

• 11.1. Beta Thalassemia Testing Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12 . COMPANY PROFILES OF BETA THALASSEMIA TESTING INDUSTRY

• 12.1. Top Company Share Analysis
• 12.2. Market Concentration Rate
• 12.3. MedGenome
  • 12.3.1. Company Overview
  • 12.3.2. Company Revenue
  • 12.3.3. Products
  • 12.3.4. Recent Developments
• 12.4. 3B BlackBio Biotech India Limited
  • 12.4.1. Company Overview
  • 12.4.2. Company Revenue
  • 12.4.3. Products
  • 12.4.4. Recent Developments
• 12.5. Bio-Rad Laboratories Inc.
  • 12.5.1. Company Overview
  • 12.5.2. Company Revenue
  • 12.5.3. Products
  • 12.5.4. Recent Developments
• 12.6. ViennaLab Diagnostics
  • 12.6.1. Company Overview
  • 12.6.2. Company Revenue
  • 12.6.3. Products
  • 12.6.4. Recent Developments
• 12.7. Thermo Fisher Scientific Inc.
  • 12.7.1. Company Overview
  • 12.7.2. Company Revenue
  • 12.7.3. Products
  • 12.7.4. Recent Developments
• 12.8. PerkinElmer Inc.
  • 12.8.1. Company Overview
  • 12.8.2. Company Revenue
  • 12.8.3. Products
  • 12.8.4. Recent Developments
• 12.9. BioMedomics Inc.
  • 12.9.1. Company Overview
  • 12.9.2. Company Revenue
  • 12.9.3. Products
  • 12.9.4. Recent Developments
• 12.10. Asper Biogene
  • 12.10.1. Company Overview
  • 12.10.2. Company Revenue
  • 12.10.3. Products
  • 12.10.4. Recent Developments
• 12.11. Tosoh Bioscience Inc.
  • 12.11.1. Company Overview
  • 12.11.2. Company Revenue
  • 12.11.3. Products
  • 12.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Kits Market Sales by Geography (USD MN)
• Consumables Market Sales by Geography (USD MN)
• Analysis Market by Technology (USD MN)
• Prenatal Diagnosis Market Sales by Geography (USD MN)
• Complete Blood Count Market Sales by Geography (USD MN)
• DNA Testing Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by Type (USD MN)
• Thalassemia Major Market Sales by Geography (USD MN)
• Thalassemia Intermedia Market Sales by Geography (USD MN)
• Analysis by End-user (USD MN)
• Hospitals & Specialty Clinics Market Sales by Geography (USD MN)
• Diagnostics Centers Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Beta Thalassemia Testing Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Beta Thalassemia Testing Report
• Market Research Process
• Market Research Methodology
• Global Beta Thalassemia Testing Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Technology
• Market Attractiveness Analysis by Type
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Kits Market Sales by Geography (USD MN)
• Consumables Market Sales by Geography (USD MN)
• Global Market Analysis by Technology (USD MN)
• Prenatal Diagnosis Market Sales by Geography (USD MN)
• Complete Blood Count Market Sales by Geography (USD MN)
• DNA Testing Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Type (USD MN)
• Thalassemia Major Market Sales by Geography (USD MN)
• Thalassemia Intermedia Market Sales by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Hospitals & Specialty Clinics Market Sales by Geography (USD MN)
• Diagnostics Centers Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.